| |
|
|
|
|
|
|
|||
|
Blood, 5 March 2009, Vol. 113, No. 10, pp. 2127-2135. Prepublished online as a Blood First Edition Paper on November 17, 2008; DOI 10.1182/blood-2008-10-178152.
PLENARY PAPER Developmental regulation of MHC II expression and transport in human plasmacytoid-derived dendritic cells1 Research Department, Institut Curie, Paris; and 2 Immunity and Cancer, Inserm U653, Paris, France
Plasmacytoid predendritic cells (pDCs) play a key role in antiviral immunity through their capacity to produce large amounts of type I interferons in response to Toll-like receptor triggering, and to differentiate into dendritic cells (DCs). However, their antigen processing and presentation pathways remain poorly characterized. In this study, we analyzed major histocompatibility complex class II (MHC II) synthesis and transport in primary human pDCs. We show that stimulation of pDCs with influenza virus leads to a sustained neosynthesis of MHC II molecules, which rapidly accumulate in antigen loading compartments organized around the microtubule organization center. MHC II endocytosis as well as antigen internalization remain active during the entire process of pDC differentiation into DCs, suggesting a capacity to constantly renew surface peptide–MHC II complexes. Formation of the intracellular pool of MHC II in activated pDCs is nuclear factor-
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2009 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||